Navigation Links
Albireo Announces Positive Results in Patients With Chronic Idiopathic Constipation From a Phase IIb trial of A3309
Date:10/12/2010

reo.

Albireo expects to present detailed results of the trial A3309-002 at upcoming scientific conferences.

Trial results

A3309-002 was a multicenter, randomized, double-blind, placebo-controlled trial conducted in the US and included 190 patients with severe constipation treated for an eight-week period. The patients included into the study were mainly female (90%) and experienced severe constipation as judged by a low number of weekly CSBMs (0.4/week). The patients had severe straining and bloating problems.

Primary endpoint

Change from Baseline in SBM Frequency during the first week of treatment

A higher frequency of SBMs occurred in all three active dose groups with statistically significant increased levels for the 10 mg and the 15 mg groups (p=0.002 and p<0.001 respectively). The numerical magnitude of change was 4.0 and 5.4 SBMs/week respectively in the two highest dose groups.

Main secondary efficacy endpoints

Change in SBM and in CSBM over the eight week treatment period

A3309 treated patients demonstrated a significant increase in average weekly CSBMs from baseline (1.0 for placebo; 2.4, 2.5 and 4.1 for 5 mg, 10 mg and 15 mg respectively and with p values being 0.021, 0.017 and <0.001 respectively). The overall change for SBMs followed the same pattern.

Time to First CSBM and Response Within 24 Hours

A3309 has a fast onset; the percentage of patients having a CSBM within 24 hours of starting therapy was 20, 31 and 55% in the active groups ((p=0.027 and p<0.001 for the two highest dose levels) compared to 10 % in the placebo group.

Other important symptoms of chronic constipation such as bloating, straining and hard stools were also relieved in higher proportions in the active dose groups.

Safety

No Serious Adverse events related to the treatment were reported.

Terminology used:

Spontaneous Bowel Movement (SBM): An SBM is
'/>"/>

SOURCE Albireo AB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Albireo Announces Positive Results From a Study With A3309 in Patients With Chronic Constipation
2. Gen-Probe Announces Webcast of Third Quarter 2010 Earnings Conference Call
3. Halozyme Therapeutics Announces Implementation of Development Focused Strategy
4. Pioneer® Surgical Technology, Inc. Announces Plans to Establish Manufacturing and Distribution Facility in Ireland
5. Webcast Alert: CEL-SCI Corp. (CVM) Announces the Biotech, Healthcare and Pharma Virtual Conference
6. IRIDEX Announces Commercial Availability of New Adjustable & Intuitive EndoProbe® Device for Eye Surgery
7. TriReme Medical Announces $17 Million Series D Financing
8. Warner Chilcott Announces FDA Approval of Next Generation Actonel
9. Arable Corporation Announces New Technology for Clinical Trial Industry
10. PharmaNet Development Group Announces Observational Research Survey
11. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , July 2, 2015 Numotion,s Board ... Officer announced that Tamas Feitel has joined ... joins Numotion after a highly successful 18 year career ... roles driving strategy, profitability, and productivity to result in ... recent position was Chief Financial Officer for GE Healthcare ...
(Date:7/2/2015)... DURHAM, N.C. , July 2, 2015 ... its acquisition of assets related to the ion channel ... that had previously been obtained as part of Pfizer,s ... all of Pfizer,s rights to the "Icagen" name and ... will provide comprehensive services for ion channel and transporter ...
(Date:7/2/2015)... TOKYO , July 2, 2015  Konica Minolta, ... today announced that it has acquired Sawae Technologica Ltda., ... Brazil , through its Brazilian healthcare ... . Local Brazil ... increasing population exceeding 200 million, significant healthcare ...
Breaking Medicine Technology:Numotion Names Tamas Feitel Chief Financial Officer 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3
... BehaviorCorp as medical director in 1990, Dr, Jerry Sheward, ... medical records (EMR) to enable the multi-location behavior health ... adults and children in the Indianapolis area and across ... apart from residing on a reliable but closed operating ...
... 2011 Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased ... interactive website, www.solosendoscopy.com on Friday July 1, ... for existing and new customers and includes comprehensive information ... look showcases streamlined navigation to allow for easy-to-use functionality, ...
Cached Medicine Technology:Aspire Indiana Works with MedInformatix to Customize Practice Management and Electronic Medical Records Solution for Psychiatric Practices 2Aspire Indiana Works with MedInformatix to Customize Practice Management and Electronic Medical Records Solution for Psychiatric Practices 3Aspire Indiana Works with MedInformatix to Customize Practice Management and Electronic Medical Records Solution for Psychiatric Practices 4Solos Endoscopy, Inc. To Launch New Corporate Website 2
(Date:7/2/2015)... ... July 02, 2015 , ... As the world becomes more connected ... how they interact with products in their everyday lives. Technology can now help homeowners ... to home entertainment and safety, as well as making kitchen tasks simpler. ...
(Date:7/2/2015)... ... , ... no secret that what we consume can have an effect on the body. And during the ... or perhaps even undernourished if not eating enough of the right foods, as well as drinking ... of year to overdo it on the food front as well, with sweet treats like ice ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... California Department of State Hospitals. Prior to using Winscribe’s dictation and clinical documentation ... dictation system to manage their organization’s dictation and transcription processes. , ...
(Date:7/2/2015)... Chicago (PRWEB) , ... July 02, 2015 , ... ... companies innovate across their products, services, channels and business models. To help manage ... is announcing the addition of Mark Benkendorf as SVP of Strategic Engagements. , ...
(Date:7/1/2015)... Livonia, Mich. (PRWEB) , ... July 01, 2015 ... ... the transition of Catholic sponsorship complete, St. Joseph’s Health, located in Syracuse, N.Y., ... "With the closing today, we have gained an admirable and important partner committed ...
Breaking Medicine News(10 mins):Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 2Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 3Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 4Health News:Iryna Lobur Shares Healthy Treats to Eat for Summer 2Health News:Patton State Hospital Saves Over 50% and Removes Document Backlogs with Winscribe Text 2Health News:Patton State Hospital Saves Over 50% and Removes Document Backlogs with Winscribe Text 3Health News:Patton State Hospital Saves Over 50% and Removes Document Backlogs with Winscribe Text 4Health News:Business Builder Mark Benkendorf Joins Innovation Firm Maddock Douglas 2Health News:St. Joseph’s Health Now a Member of Trinity Health 2Health News:St. Joseph’s Health Now a Member of Trinity Health 3Health News:St. Joseph’s Health Now a Member of Trinity Health 4
... sideline even the best athletes, but a new study ... indicates that the use of minimally invasive arthroscopic surgery ... athletes who undergo the procedure another opportunity to resume ... , The researchers at Rush determined that 78 percent ...
... Gardner HealthDay Reporter , SUNDAY, July 18 ... participate in clinical trials for HIV vaccines end up ... they,re not actually infected, a new study shows. ... (VISP), meaning that they possess immune system antibodies to ...
... Sayadi and Joel Herskowitz. They are a wife-husband team ... problems are everywhere and they can be deadly., "Many ... the elderly," said Sayadi, a speech-language pathologist with the Natick ... many things to prevent falls. But not many people realize ...
... of Technology not only involves its students in research, ... innovations. An example of recently licensed university technology is ... in the laboratory. Associate Professor Nasri Nesnas was ... a commonly used laboratory research tool. Most often, neuroscientists ...
... By Amanda Gardner HealthDay Reporter , THURSDAY, July ... panel recommended that the controversial diabetes drug Avandia stay on ... organizations are urging patients not to change their medications before ... use of Avandia to drop off markedly, however. "Why ...
... prey, chemical signals called kairomones serve as an early-warning ... detected by their prey, and can even trigger adaptations, ... help protect the prey. But as widespread as kairomones ... remained largely unknown. New research by Rockefeller University,s Joel ...
Cached Medicine News:Health News:New study finds arthroscopic hip surgery may fully restore function in athletes 2Health News:Many False-Positive HIV Test Results for Those in AIDS Vaccine Trials 2Health News:Many False-Positive HIV Test Results for Those in AIDS Vaccine Trials 3Health News:Swallowing safely is no choke 2Health News:Diabetics Urged to Confer With Their Doctor About Avandia Use 2Health News:Diabetics Urged to Confer With Their Doctor About Avandia Use 3Health News:Scientists identify nature's insect repellents 2
... Digital Flexible Ureteroscope (DUR-D) incorporates many ... proven durable, market leading DUR® series ... first device utilizing Gyrus ACMIs proprietary, ... Metal Oxide Semi-Conductor (CMOS) distal sensor ...
... is the first one-step 20 minutes rapid test ... 2 produced by Enterohemorrhagic Escherichia coli in human ... enrichment of fecal specimens and detects all Toxigenic ... separate result for Toxin 1 and 2 is ...
Inquire...
... elegant and sophisticated woman, the ... ophthalmic and sunwear styles. Frames ... of shapes and colors, designed ... and complexions. Many styles feature ...
Medicine Products: